28th Mar 2006 07:00
Celsis International PLC28 March 2006 CELSIS INTERNATIONAL PLC Pre-Close Trading Update 28 March 2006: Celsis International plc ("Celsis" or the "Company"), the rapidmicrobial detection and analytical services company, today announces an updateon trading prior to the close of its financial year. The Company has made good progress in the year, especially from strong secondhalf performance from the Laboratory Group. The Product Group continues toperform well and as a result, the company is on track to announce profits inline with the Board's expectations for the year ended 31 March 2006. Celsis will announce its preliminary results for the year ended 31 March 2006,on Wednesday 14 June 2006. There will be a presentation to analysts on the dayat 9.30am, held at Financial Dynamics, Holborn Gate, 26 Southampton Buildings,London, WC2A 1PB. Jay LeCoque, Chief Executive Officer, of Celsis International plc commented: "Celsis has continued to see healthy trading in the second half of the year andI am pleased to report that the Company is set to report another set of year endresults that are in line with Board expectations. Our Laboratory Group strategyto focus on higher margin services has been particularly successful during thesecond half of the year and we expect this business to continue to grow morestrongly into our new fiscal year. The Product Group remains the leader in its selected fields of interest andcontinues to benefit from Celsis' unmatched global presence, which we believe tobe a significant advantage as we grow this business further. Overall, Celsis ison track to retain its high levels of profitability and we are very confidentabout the Company's future prospects to develop the business both organicallyand through acquisition opportunities." Enquiries:Celsis International plc Tel: 01638 600 151Jay LeCoque, Chief Executive OfficerJenny Parsons, Corporate CommunicationsFinancial Dynamics Tel: 020 7831 3113 Ben AtwellDavid Yates Notes to editors Celsis International plc Celsis International plc is a rapid microbial detection and analytical servicescompany. The company is listed on the London Stock Exchange (CEL.L). Using proprietary technology, the Product Group is the world leader in theprovision of diagnostic systems for the rapid detection of microbialcontamination. It works in close collaboration with many of the world's leadingpharmaceutical, personal care and beverage companies, ensuring the safety andquality of products bound for consumers. The Laboratory Group providesoutsourced analytical testing services to pharmaceutical and biopharmaceuticalcompanies to ensure the stability and chemical composition of their products. In addition to ensuring product quality and safety for consumers, both divisionshave the capacity to deliver substantial cost savings to Celsis' customers. Byreducing the time it takes to test and release raw materials and finished goodsto the market place, Celsis' products facilitate increased manufacturingproductivity and improved supply chain management. Further information can be found on its website at www.celsis.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Celadon Pharmaceuticals